Literature DB >> 16278516

Significant involvement of chromosome 13q deletions in progression of larynx cancer, detected by comparative genomic hybridization.

Kamilla Schlade-Bartusiak1, Agnieszka Stembalska, David Ramsey.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of tumours with various clinical characteristics. These tumours generally exhibit complex karyotypes. Few studies of genomic imbalances have been performed exclusively in subgroups of larynx cancer samples at different stages of the disease. In the present study, chromosomal gains and losses were investigated in 52 larynx tumours, by using comparative genomic hybridization (CGH). The mean number of observed alterations was 37.7 per tumour. The most common sites of losses were 1p, 13q, Xp, and the most common gains were located in 1p, 9q, 16q. The overall number of gains was negatively associated with cancer grading. G1 tumours were also characterized by a higher frequency of deletions in 13q32 and amplifications in 1q23, than tumours in other grades (p < 0.05). The frequency of losses of 13q22 also positively associated with tumour size. There was no association between the frequency of losses in 13q and the presence of lymph node metastases at the time of diagnosis. Another statistically significant association was observed for gains at 1q22-23 and tumour size (p < 0.01). No statistically significant difference in the frequency of most common imbalances was detected between primary tumours with lymph node metastases and those without metastases. In conclusion, we discovered a significant involvement of 13q deletions in the progression of larynx cancer. All the other significant changes observed in the present study were reported previously as being important for HNSCC progression. It seems that multiple genes are disrupted in the process of neoplastic transformation in the larynx, and the networks of events remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278516

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  6 in total

1.  Chromosomal imbalances exclusively detected in invasive front area are associated with poor outcome in laryngeal carcinomas from different anatomical sites.

Authors:  Eliane Papa Ambrosio; Cássia Gisele Terrassani Silveira; Sandra Aparecida Drigo; Vivian de Souza Sacomano; Miriam Coelho Molck; Rafael Malagoli Rocha; Maria Aparecida Custódio Domingues; Fernando Augusto Soares; Luiz Paulo Kowalski; Silvia Regina Rogatto
Journal:  Tumour Biol       Date:  2013-06-08

2.  Increased expression of cellular retinol-binding protein 1 in laryngeal squamous cell carcinoma.

Authors:  Raúl Peralta; Michael Baudis; Guelaguetza Vazquez; Sergio Juárez; Rocío Ortiz; Horacio Decanini; Dulce Hernandez; Francisco Gallegos; Alejandra Valdivia; Patricia Piña; Mauricio Salcedo
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-07       Impact factor: 4.553

3.  Cancer of the larynx in Puerto Rico.

Authors:  Albert Villanueva-Reyes; Edythe Strand; Cruz María Nazario; Margarita Irizarry-Ramírez
Journal:  P R Health Sci J       Date:  2008-09       Impact factor: 0.705

4.  Evaluation of 13q14 status in multiple myeloma by digital single nucleotide polymorphism technology.

Authors:  Katy Hanlon; Lorna W Harries; Sian Ellard; Claudius E Rudin
Journal:  J Mol Diagn       Date:  2009-07-30       Impact factor: 5.568

5.  Evaluation of 13q14 status in patients with chronic lymphocytic leukemia using single nucleotide polymorphism-based techniques.

Authors:  Katy Hanlon; Sian Ellard; Claudius E Rudin; Susan Thorne; Teresa Davies; Lorna W Harries
Journal:  J Mol Diagn       Date:  2009-05-21       Impact factor: 5.568

6.  Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).

Authors:  Katy Hanlon; Claudius E Rudin; Lorna W Harries
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.